Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Mengyin Cai"'
Publikováno v:
Nutrition & Diabetes, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Background The effectiveness of ketogenic diet (KD) in ameliorating fatty liver has been established, although its mechanism is under investigation. Fibroblast growth factor 21 (FGF21) positively regulates obesity-associated metabolic disord
Externí odkaz:
https://doaj.org/article/0228035661504c8fa0037f65197ae123
Autor:
Huanyi Cao, Qingxian Cai, Wanrong Guo, Qiao Su, Hancheng Qin, Tian Wang, Yingxin Xian, Longyi Zeng, Mengyin Cai, Haixia Guan, Sifan Chen, Hua Liang, Fen Xu
Publikováno v:
Cell Reports, Vol 42, Iss 4, Pp 112319- (2023)
Summary: Protein post-translational modifications (PTMs) participate in important bioactive regulatory processes and therefore can help elucidate the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Here, we investigate the involvement of P
Externí odkaz:
https://doaj.org/article/455c0e4668144867ae89719ff16b07d9
Publikováno v:
Endocrine Connections, Vol 9, Iss 9, Pp 946-954 (2020)
Background: Obesity is associated with the development and progression of c hronic kidney disease. Emerging evidence suggests that glucagon-like p eptide-1 receptor agonist could reduce renal damage and albuminuria. Sirtuin 1 (S IRT1) was considered
Externí odkaz:
https://doaj.org/article/8ab9070512dc4b0eaf34436c4a38cdbd
Publikováno v:
Advances in Engineering Technology Research. 4:194
The reading of a thermocouple is not equal to the gas temperature because of the complicated heat transfer process among the thermocouple, the gas, and the environment. So the corrections for thermocouple measurements are necessary to obtain the real
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1829d0e7a754fb398567a4270322a13e
https://doi.org/10.56028/aetr.4.1.194.2023
https://doi.org/10.56028/aetr.4.1.194.2023
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Xiling Hu,1,* Yao Zhang,2,* Shuo Lin,2 Xiaodi Guo,2 Dan Yang,3 Mengyin Cai,2,* Lingling Gao3,* 1Department of Medicine, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People’s Republic of China; 2Department of Endocrinology and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5447da393b25b9b9ddc7dd753a94c5f8
http://europepmc.org/articles/PMC7815068
http://europepmc.org/articles/PMC7815068
Publikováno v:
Endocrine Connections
Endocrine Connections, Vol 9, Iss 9, Pp 946-954 (2020)
Endocrine Connections, Vol 9, Iss 9, Pp 946-954 (2020)
Background: Obesity is associated with the development and progression of chronic kidney disease. Emerging evidence suggests that glucagon-like peptide-1 receptor agonist could reduce renal damage and albuminuria. Sirtuin 1 (SIRT1) was considered as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cbd4a7e1f68cd0bf549b63eeda67cd5
http://europepmc.org/articles/PMC7583131
http://europepmc.org/articles/PMC7583131
Autor:
Xixiang Tang, Jiong Shu, Shuo Lin, Jing Wang, Panwei Mu, Mengyin Cai, Hua Liang, Bai-Run Lin, Yanming Chen, Yina Wang, Yong-jun Zhang, Man-man Wang, Ying Tan
Publikováno v:
Journal of Diabetes
Background In this study, we compared the effect on diabetic retinopathy (DR) between oral antidiabetic drugs (OADs) alone and in combination with basal insulin‐supported OADs therapy (BOT). [Correction added on 11 November 2019, after first online
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87c3fd493612070350ba88061ebd38eb
https://doi.org/10.1111/1753-0407.12928
https://doi.org/10.1111/1753-0407.12928
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Xiling Hu,1,* Hongrong Deng,2,* Yao Zhang,2 Xiaodi Guo,2 Mengyin Cai,2 Cong Ling,3,* Kun Li4,* 1Department of Medicine, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, People’s Republic of China; 2Department of Endocrinology and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2e8fdccb15c1e11288d43f1a4323581
https://www.dovepress.com/efficacy-and-safety-of-a-decision-support-intervention-for-basal-insul-peer-reviewed-article-DMSO
https://www.dovepress.com/efficacy-and-safety-of-a-decision-support-intervention-for-basal-insul-peer-reviewed-article-DMSO
Publikováno v:
Diabetes. 69
Recent studies have indicated apoptosis to be a major contributor to the progression of Diabetic Kidney Disease. GLP-1 agonist such as Exenatide, which counteracts insulin resistance in humans with type 2 diabetes, has been shown to ameliorate Diabet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dce4c799ad93f42d08034fe02a54bc30
https://doi.org/10.2337/db20-520-p
https://doi.org/10.2337/db20-520-p
Publikováno v:
Hepatology. 66:809-824
Recent studies have indicated that lipid-induced endoplasmic reticulum (ER) stress is a major contributor to the progression of hepatic steatosis. Exenatide (exendin-4), a glucagon-like peptide-1 receptor agonist, is known to improve hepatic steatosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f99caa844de7d607b6693c20da4003c9
https://doi.org/10.1002/hep.29238
https://doi.org/10.1002/hep.29238